Zolmax Cocrystal Pharma (NASDAQ:COCP - Free Report) had its price objective cut by HC Wainwright from $10.00 to $7.00 in a research note published on Thursday morning, Benzinga reports. They currently have...\n more…
Ticker Report Cocrystal Pharma (NASDAQ:COCP - Free Report) had its price objective trimmed by HC Wainwright from $10.00 to $7.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a...\n more…
Ticker Report Cocrystal Pharma, Inc. (NASDAQ:COCP - Free Report) - Analysts at Zacks Small Cap raised their FY2024 earnings estimates for Cocrystal Pharma in a research report issued to clients and investors on...\n more…
TipRanks Financial Blog Cocrystal Pharma (COCP) has issued an update. Cocrystal Pharma, Inc. has announced its plans to participate in upcoming investment conferences, signaling an opportu...\n more…
Ticker Report Cocrystal Pharma, Inc. (NASDAQ:COCP - Free Report) - Analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Cocrystal Pharma in a note issued to investors on Thursday...\n more…